Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Botto

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|June 20, 1998
Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonistC Labbé-Jullié, S Barroso, D Nicolas-Etève, et al.
Genes and Immunity|September 1, 2006
Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosusY Heidari, A E Bygrave, R J Rigby, et al.
Clinical Rheumatology|June 1, 1994
Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapyM L Pacor, D Biasi, C Lunardi, et al.
Nature Genetics|May 20, 1998
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodiesM Botto, C Dell'Agnola, A E Bygrave, et al.
Molecular Pharmacology|May 1, 1995
[3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptorC Labbé-Jullié, J M Botto, M V Mas, et al.
Blood|November 15, 1996
Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell lineK Nason-Burchenal, D Gandini, M Botto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient miceM G Robson, H T Cook, M Botto, et al.
QJM : Monthly Journal of the Association of Physicians|October 1, 1994
C3 nephritic factor and SLE: report of four cases and review of the literatureM J Walport, K A Davies, M Botto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 31, 1998
Identification of the receptor subtype involved in the analgesic effect of neurotensinI Dubuc, P Sarret, C Labbé-Jullié, et al.
Nature Medicine|August 1, 1997
Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component geneM Botto, P N Hawkins, M C Bickerstaff, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|June 20, 1998
Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonistC Labbé-Jullié, S Barroso, D Nicolas-Etève, et al.
Genes and Immunity|September 1, 2006
Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosusY Heidari, A E Bygrave, R J Rigby, et al.
Clinical Rheumatology|June 1, 1994
Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapyM L Pacor, D Biasi, C Lunardi, et al.
Nature Genetics|May 20, 1998
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodiesM Botto, C Dell'Agnola, A E Bygrave, et al.
Molecular Pharmacology|May 1, 1995
[3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptorC Labbé-Jullié, J M Botto, M V Mas, et al.
Blood|November 15, 1996
Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell lineK Nason-Burchenal, D Gandini, M Botto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient miceM G Robson, H T Cook, M Botto, et al.
QJM : Monthly Journal of the Association of Physicians|October 1, 1994
C3 nephritic factor and SLE: report of four cases and review of the literatureM J Walport, K A Davies, M Botto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 31, 1998
Identification of the receptor subtype involved in the analgesic effect of neurotensinI Dubuc, P Sarret, C Labbé-Jullié, et al.
Nature Medicine|August 1, 1997
Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component geneM Botto, P N Hawkins, M C Bickerstaff, et al.
Pageof 10